Please login to the form below

Not currently logged in
Email:
Password:

New accounts: November

The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period August to October 2005 inclusive

The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period August to October 2005 inclusive. Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may also be involved with some of the products listed in other ways, or in domestic, overseas or international markets. To submit an entry for New Accounts, email nhobson@pmlive.com.

Bristol-Myers Squibb

New product

Ultrasound contrast agents

PAN Advertising

Cardinal Health

Physeptone

Addiction

Lowe Azure

Cardinal Health Martindale Products

Pre-filled syringes

Hospital speciality

Pulsar Healthcare Communications

Link Pharmaceuticals

Gliadel implant

Oncology

Addjuice

Mayne Pharma

N/A

Full portfolio

Swordfish Advertising

Napp Pharmaceuticals

BuTrans

Pain relief

Langland

Roche

New product

Oncology

MJL

Royal Free Hospital

Fundraising

HIV/HCV/HBV

MJL

Royal Numico (global)

Cubitan

Woundcare nutrition

central

Royal Numico (global)

Cubison

Woundcare nutrition

central

Wyeth

Efexor XL

Psychiatry

PAN Advertising

2nd September 2008

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Viseven

Viseven is a full cycle digital agency with 10 years expertise in developing content for the global pharmaceutical market delivering...

Latest intelligence

Virtual meeting technologies for reducing emissions and waste in the healthcare industry
...
Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...